
    
      In this study, 48 patients with hyperphosphatemia were enrolled in four incremental dose
      groups (1.5g, 3g, 4.5g, 6g), which were randomly divided into experimental group, control
      group and placebo group.In this study, sentinel group was used. Two subjects in the same dose
      group were first given lanthanum polystyrene sulfonate powder , after 96 hours of
      observation, the remaining subjects were randomly given the test drug, positive control group
      or placebo in the proportion of 3:1:1; the subjects in different dose groups were
      successively enrolled in the group, and after the end of the former group, whether to carry
      out multiple dose studies in the higher dose group would be determined according to the
      tolerance results and pharmacokinetic characteristics.
    
  